Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2010

01.12.2010 | Research Article

Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals

verfasst von: Francesc Puigventós, Bernardo Santos-Ramos, Ana Ortega, Esther Durán-García

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective Define the structure and working procedures of the Pharmacy and Therapeutic Committees (P&T Committees) in Spanish hospitals. Setting Hospitals over 75 beds located in all regions of the Spanish State. Method A cross-sectional descriptive study based on the completion of a questionnaire that consisted of 138 questions. The participants were recruited by post, e-mail and telephone between November 2007 and January 2008. The Hospitals were classified according to their size and public or private and university or non-university status. Main outcome measures They are related with the structure and composition of the P&T Committees, performance, drug evaluation process, working methods and the results of their activity. Results A total of 200 hospitals answered the questionnaire (response rate of 39.0% of hospitals and 57.1% of the beds in Spain). All the hospitals have P&T Committees, 99.5% have a Drug Formulary, 71.0% have a Therapeutic Interchange Programme and 91.0% have a document determining the mission, objectives and functions of the P&T Committee. Almost all hospitals (95.5%) have established a formal application for the inclusion of a drug in the hospital, while 80.5% have established a model for evaluation reports. The mean (SD) number of participants in P&T Committees was 11.84 (3.82). The annual mean of drugs evaluated per hospital was 10.35 (7.45). The proportion of assessments that concludes the inclusion, rejection or deferral of the decision was 75.3, 21.4 and 3.2%, respectively. Conclusion Spanish P&T Committees have a similar structure and function, a multi-disciplinary professional composition to carry out an important assessment activity. This activity is higher in large hospitals and in university hospitals. The proportion of the approved and rejected drugs is similar in different types of hospital. The Therapeutic Interchange Guidelines, the use of application models and the reports follow the indications of scientific collaborative groups, thus being used more in Spain than in other countries.
Literatur
1.
Zurück zum Zitat Mannebach MA, Ascione FJ, Gaither Ca, Baggozi RP, Cohen IA, Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health-Syst Pharm. 1999;56:622–8.PubMed Mannebach MA, Ascione FJ, Gaither Ca, Baggozi RP, Cohen IA, Ryan ML. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals. Am J Health-Syst Pharm. 1999;56:622–8.PubMed
2.
Zurück zum Zitat Tyler LS, Cole SW, May JR, Millares M, Valentino MA, Vermeulen LC Jr, et al. ASHP Expert Panel on Formulary Management. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health-Syst Pharm. 2008;65:1272–83.CrossRefPubMed Tyler LS, Cole SW, May JR, Millares M, Valentino MA, Vermeulen LC Jr, et al. ASHP Expert Panel on Formulary Management. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health-Syst Pharm. 2008;65:1272–83.CrossRefPubMed
3.
Zurück zum Zitat Fijn R, Brouwers JR, Knaap RJ. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures. Br J Clin Pharmacol. 1999;48:239–46.CrossRefPubMed Fijn R, Brouwers JR, Knaap RJ. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures. Br J Clin Pharmacol. 1999;48:239–46.CrossRefPubMed
4.
Zurück zum Zitat Pedersen CA, Schneider PJ, Santell JP. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing–2001. Am J Health-Syst Pharm. 2001;58:2251–66.PubMed Pedersen CA, Schneider PJ, Santell JP. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing–2001. Am J Health-Syst Pharm. 2001;58:2251–66.PubMed
5.
Zurück zum Zitat Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing–2004. Am J Health-Syst Pharm. 2005;62:378–90.PubMed Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing–2004. Am J Health-Syst Pharm. 2005;62:378–90.PubMed
6.
Zurück zum Zitat Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany’. Eur J Clin Pharmacol. 1997;52:429–35.CrossRefPubMed Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany’. Eur J Clin Pharmacol. 1997;52:429–35.CrossRefPubMed
7.
Zurück zum Zitat Tan EL, Day RO, Brien JA. Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharm World Sci. 2007;29:90–6.CrossRefPubMed Tan EL, Day RO, Brien JA. Prioritising drug and therapeutics committee (DTC) decisions: a national survey. Pharm World Sci. 2007;29:90–6.CrossRefPubMed
8.
Zurück zum Zitat Cooke J, Mason AR, Drummond MF, Towse AK. Medication management in English National Health Service hospitals. Am J Health-Syst Pharm. 2005;62:189–95.PubMed Cooke J, Mason AR, Drummond MF, Towse AK. Medication management in English National Health Service hospitals. Am J Health-Syst Pharm. 2005;62:189–95.PubMed
9.
Zurück zum Zitat Willems L, Raymakers A, Sermeus W, Vleugels A, Laekeman G. Survey of hospital pharmacy practice in Flemish-speaking Belgium. Am J Health-Syst Pharm. 2005;62:321–4.PubMed Willems L, Raymakers A, Sermeus W, Vleugels A, Laekeman G. Survey of hospital pharmacy practice in Flemish-speaking Belgium. Am J Health-Syst Pharm. 2005;62:321–4.PubMed
10.
Zurück zum Zitat Mittmann N, Knowles S. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities. Can J Clin Pharmacol. 2009;16:e171–7.PubMed Mittmann N, Knowles S. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities. Can J Clin Pharmacol. 2009;16:e171–7.PubMed
11.
Zurück zum Zitat Shalansky SJ, Virk R, Ackman M, Jackevicius C, Kertland H, Tsuyuki R, et al. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process. Can J Cardiol. 2003;19:173–9.PubMed Shalansky SJ, Virk R, Ackman M, Jackevicius C, Kertland H, Tsuyuki R, et al. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process. Can J Cardiol. 2003;19:173–9.PubMed
14.
Zurück zum Zitat Marín R, Santos B, Briones E, Flores S, Gallego S, Bautista J. Implementation of the guidelines for the introduction of new drugs (GINF) in Andalusian hospitals. Farm Hosp. 2007;31:212–7.CrossRef Marín R, Santos B, Briones E, Flores S, Gallego S, Bautista J. Implementation of the guidelines for the introduction of new drugs (GINF) in Andalusian hospitals. Farm Hosp. 2007;31:212–7.CrossRef
16.
Zurück zum Zitat Walk SU, Bertsche T, Kaltschmidt J, Pruszydlo MG, Hoppe-Tichy T, Walter-Sack I, et al. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol. 2008;64:319–27.CrossRefPubMed Walk SU, Bertsche T, Kaltschmidt J, Pruszydlo MG, Hoppe-Tichy T, Walter-Sack I, et al. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol. 2008;64:319–27.CrossRefPubMed
17.
Zurück zum Zitat Gray T, Bertch K, Galt K, Gonyeau M, Karpiuk E, Oyen L, et al. American College of Clinical Pharmacy. Guidelines for therapeutic interchange—2004. Pharmacotherapy. 2005;11:1666–80.CrossRef Gray T, Bertch K, Galt K, Gonyeau M, Karpiuk E, Oyen L, et al. American College of Clinical Pharmacy. Guidelines for therapeutic interchange—2004. Pharmacotherapy. 2005;11:1666–80.CrossRef
18.
Zurück zum Zitat Delgado O, Puigventós F, Llodrá V, Comas F, Cervera M, Sánchez A, et al. Program for the substitution of therapeutic equivalents in the hospital setting. Rev Clin Esp. 2000;200:261–70. Delgado O, Puigventós F, Llodrá V, Comas F, Cervera M, Sánchez A, et al. Program for the substitution of therapeutic equivalents in the hospital setting. Rev Clin Esp. 2000;200:261–70.
19.
Zurück zum Zitat Porta B, Borras C, Jimenez NV. Therapeutic interchange standardization for angiotensin II receptor antagonists in the treatment of hypertension in the hospital setting. Farm Hosp. 2005;29:104–12.CrossRef Porta B, Borras C, Jimenez NV. Therapeutic interchange standardization for angiotensin II receptor antagonists in the treatment of hypertension in the hospital setting. Farm Hosp. 2005;29:104–12.CrossRef
20.
Zurück zum Zitat Peris JF, Faus VJ, de la Vega A, Martines G, Martínez MA. Therapeutic interchange between angiotensin II receptor blockers in institutionalized elderly patients: implementing a protocol. Farm Hosp. 2003;27:290–7. Peris JF, Faus VJ, de la Vega A, Martines G, Martínez MA. Therapeutic interchange between angiotensin II receptor blockers in institutionalized elderly patients: implementing a protocol. Farm Hosp. 2003;27:290–7.
21.
Zurück zum Zitat Navarro S, Font I, Lerma E, López E, Martínez MJ, Poveda JL. Therapeutic interchange of drugs not included in the hospitals pharmacotherapeutic guide: a quality programme. Farm Hosp. 2004;28:266–74. Navarro S, Font I, Lerma E, López E, Martínez MJ, Poveda JL. Therapeutic interchange of drugs not included in the hospitals pharmacotherapeutic guide: a quality programme. Farm Hosp. 2004;28:266–74.
22.
Zurück zum Zitat Márquez-Peiró JF, Porta-Oltra B, Borrás-Almenar C. Therapeutic exchange of angiotensin II receptor antagonists in patients hospitalised in a thraumatology unit. Farm Hosp. 2009;33:66–71.CrossRefPubMed Márquez-Peiró JF, Porta-Oltra B, Borrás-Almenar C. Therapeutic exchange of angiotensin II receptor antagonists in patients hospitalised in a thraumatology unit. Farm Hosp. 2009;33:66–71.CrossRefPubMed
23.
Zurück zum Zitat Crespí M, Delgado O, Ventayol P, Lafuente A, Pinteño M, Escrivá A, et al. A prospective randomized study of sulphonylureas therapeutic interchange in patients with type 2 diabetes mellitus. Farm Hosp. 2004;28:426–32. Crespí M, Delgado O, Ventayol P, Lafuente A, Pinteño M, Escrivá A, et al. A prospective randomized study of sulphonylureas therapeutic interchange in patients with type 2 diabetes mellitus. Farm Hosp. 2004;28:426–32.
25.
Zurück zum Zitat Fry RN, Avey SG, Sullivan SD. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard—a Foundation for Managed Care Pharmacy Task Force report. Value Health. 2003;6:505–21.CrossRefPubMed Fry RN, Avey SG, Sullivan SD. The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard—a Foundation for Managed Care Pharmacy Task Force report. Value Health. 2003;6:505–21.CrossRefPubMed
Metadaten
Titel
Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals
verfasst von
Francesc Puigventós
Bernardo Santos-Ramos
Ana Ortega
Esther Durán-García
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2010
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9435-4

Weitere Artikel der Ausgabe 6/2010

International Journal of Clinical Pharmacy 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.